NPDev Labs

NPDev Trends · What a country is searching for, explained from its coverage

Trending search

tirzepatide

Approximate search volume: 1000+First seen 2026-10-02 15:19 UTCLast seen 2026-10-02 15:49 UTCUnited Kingdom

No explainer has been written about this search yet. Explanations are written at most once an hour, and only when a search has new coverage, from the stored headlines below.

Related coverage stored for this search

Headlines and links only, as the publishers' feed carried them. Headline-only coverage: this site has not read any of these articles.

  1. [1]Lilly’s Next-Gen Obesity Drug Helps People Lose Even More Weight in Study

    WSJ · first seen 2026-10-02 15:19 UTC · last seen 2026-10-02 15:34 UTC

  2. [2]Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s

    CNBC · first seen 2026-10-02 15:34 UTC · last seen 2026-10-02 15:49 UTC

  3. [3]Experimental Lilly combination drug tops Zepbound in weight-loss trial

    Reuters · first seen 2026-10-02 15:19 UTC · last seen 2026-10-02 15:49 UTC

  4. [4]‘Godzilla’ of weight-loss drugs could provide other important health benefits

    The Guardian · first seen 2026-10-02 15:19 UTC · last seen 2026-10-02 15:49 UTC

  5. [5]Blockbuster retatrutide trial signals a ‘new high-water mark’ for weight-loss drugs

    Scientific American · first seen 2026-10-02 15:34 UTC · last seen 2026-10-02 15:34 UTC

Feed history for this search

Seen in the feed 3 times between 2026-10-02 15:19 UTC and 2026-10-02 15:49 UTC. Each read is stored with the label and headline count the feed carried then; the search keeps that history here after it stops trending.

  1. 2026-10-02 15:49 UTCpublisher's label 1000+ · 5 related headlines

  2. 2026-10-02 15:34 UTCpublisher's label 1000+ · 5 related headlines · 2 new

  3. 2026-10-02 15:19 UTCpublisher's label 1000+ · 3 related headlines · 3 new

Comments and bookmarks

Comments are plain text from NPDev accounts. Bookmarks stay private to the account that saved them.

No comments yet. Be the first to say something.

Sign in to join the conversation.

Also trending